Skip to main content
. 2011 Apr 7;118(4):874–883. doi: 10.1182/blood-2010-06-292615

Table 3.

Distribution of treatment failures (randomized patients only)

T-ALL
T-NHL
Total
No HDM (n = 151) HDM (n = 148) No HDM (n = 66) HDM (n = 71) No HDM (n = 217) HDM (n = 219)
Total failures 50 35 9 14 59 49
Induction failures 14 7 1 1 15 8
Induction deaths 1 2 0 0 1 2
Relapse 28 20 5 10 33 30
    Marrow only 4 8 1 1 5 9
    Marrow + CNS 7 1 0 0 7 1
    Marrow + testicular 0 0 0 1 0 1
    Marrow + Mediastinal 1 2 0 1 1 3
    Marrow + other 1* 1 0 1* 1 2
    Isolated CNS 11 7 1 2 12 9
    Isolated testicular 1 1 0 0 1 1
    Mediastinal ± other 0 0 2§ 3 2 3
    Lymph 0 0 1 1 1 1
    Unspecified 3 0 0 0 3 0
Second malignancy 4 4 2 1 6 5
Remission deaths 3 2 1 2 4 4

T-ALL indicates T-cell acute lymphoblastic leukemia; T-NHL, T-cell lymphoblastic non-Hodgkin lymphoma; and HDM, high-dose methotrexate.

*

One lymph.

One spleen.

One eye.

§

One pleura.

One lung.